{"id":"https://openalex.org/W2587007231","doi":"https://doi.org/10.18632/oncotarget.15169","title":"A NOTCH-sensitive uPAR-regulated oncolytic adenovirus effectively suppresses pancreatic tumor growth and triggers synergistic anticancer effects with gemcitabine and nab-paclitaxel","display_name":"A NOTCH-sensitive uPAR-regulated oncolytic adenovirus effectively suppresses pancreatic tumor growth and triggers synergistic anticancer effects with gemcitabine and nab-paclitaxel","publication_year":2017,"publication_date":"2017-02-07","ids":{"openalex":"https://openalex.org/W2587007231","doi":"https://doi.org/10.18632/oncotarget.15169","mag":"2587007231","pmid":"https://pubmed.ncbi.nlm.nih.gov/28186974","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5410256"},"language":"en","primary_location":{"id":"doi:10.18632/oncotarget.15169","doi":"https://doi.org/10.18632/oncotarget.15169","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.15169","pdf_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=15169&path%5B%5D=48514","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=15169&path%5B%5D=48514","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046300715","display_name":"Ana Mato-Berciano","orcid":"https://orcid.org/0009-0005-0811-3581","observed_orcids":["https://orcid.org/0009-0005-0811-3581"]},"institutions":[{"id":"https://openalex.org/I4210111366","display_name":"Centre for Biomedical Network Research on Rare Diseases","ror":"https://ror.org/01ygm5w19","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210111366"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ana Mato-Berciano","raw_affiliation_strings":["Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain","Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain","institution_ids":["https://openalex.org/I4210111366"]},{"raw_affiliation_string":"Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain","institution_ids":["https://openalex.org/I4210160192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012811472","display_name":"Giulia Raimondi","orcid":"https://orcid.org/0000-0003-2737-4072","observed_orcids":["https://orcid.org/0000-0003-2737-4072"]},"institutions":[{"id":"https://openalex.org/I4210111366","display_name":"Centre for Biomedical Network Research on Rare Diseases","ror":"https://ror.org/01ygm5w19","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210111366"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Giulia Raimondi","raw_affiliation_strings":["Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain","Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain","institution_ids":["https://openalex.org/I4210111366"]},{"raw_affiliation_string":"Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain","institution_ids":["https://openalex.org/I4210160192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026232524","display_name":"Mar\u00eda Victoria Maliandi","orcid":"https://orcid.org/0000-0001-5447-2343","observed_orcids":["https://orcid.org/0000-0001-5447-2343"]},"institutions":[{"id":"https://openalex.org/I4210111366","display_name":"Centre for Biomedical Network Research on Rare Diseases","ror":"https://ror.org/01ygm5w19","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210111366"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria Victoria Maliandi","raw_affiliation_strings":["Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain","Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain","institution_ids":["https://openalex.org/I4210111366"]},{"raw_affiliation_string":"Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain","institution_ids":["https://openalex.org/I4210160192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084444653","display_name":"Ram\u00f3n Alemany","orcid":"https://orcid.org/0000-0001-8660-550X","observed_orcids":["https://orcid.org/0000-0001-8660-550X"]},"institutions":[{"id":"https://openalex.org/I4210087039","display_name":"Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge","ror":"https://ror.org/0008xqs48","country_code":"ES","type":"facility","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210087039","https://openalex.org/I4210096656","https://openalex.org/I4210106543","https://openalex.org/I4210107147","https://openalex.org/I4210153292","https://openalex.org/I4387153040","https://openalex.org/I71999127"]},{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ramon Alemany","raw_affiliation_strings":["Institut Catal\u00e0 d'Oncologia-IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Catal\u00e0 d'Oncologia-IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain","institution_ids":["https://openalex.org/I4210087039","https://openalex.org/I4210107147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076889486","display_name":"Llu\u00eds Montoliu","orcid":"https://orcid.org/0000-0003-3941-1176","observed_orcids":["https://orcid.org/0000-0003-3941-1176"]},"institutions":[{"id":"https://openalex.org/I4210104776","display_name":"Centro Nacional de Biotecnolog\u00eda","ror":"https://ror.org/015w4v032","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I4210104776"]},{"id":"https://openalex.org/I4210111366","display_name":"Centre for Biomedical Network Research on Rare Diseases","ror":"https://ror.org/01ygm5w19","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210111366"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Lluis Montoliu","raw_affiliation_strings":["Centro Nacional de Biotecnologia (CNB-CSIC), Madrid, Spain","Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Nacional de Biotecnologia (CNB-CSIC), Madrid, Spain","institution_ids":["https://openalex.org/I4210104776"]},{"raw_affiliation_string":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain","institution_ids":["https://openalex.org/I4210111366"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066082571","display_name":"Cristina Fillat","orcid":"https://orcid.org/0000-0002-0801-3338","observed_orcids":["https://orcid.org/0000-0002-0801-3338"]},"institutions":[{"id":"https://openalex.org/I4210111366","display_name":"Centre for Biomedical Network Research on Rare Diseases","ror":"https://ror.org/01ygm5w19","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210111366"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Cristina Fillat","raw_affiliation_strings":["Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain","Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain","institution_ids":["https://openalex.org/I4210111366"]},{"raw_affiliation_string":"Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain","institution_ids":["https://openalex.org/I4210160192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5066082571"],"corresponding_institution_ids":["https://openalex.org/I4210111366","https://openalex.org/I4210160192"],"apc_list":null,"apc_paid":null,"fwci":1.6993,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":{"value":0.83216093,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"8","issue":"14","first_page":"22700","last_page":"22715"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oncolytic-adenovirus","display_name":"oncolytic adenovirus","score":0.9399999976158142},{"id":"https://openalex.org/keywords/notch-signaling","display_name":"Notch signaling","score":0.859000027179718},{"id":"https://openalex.org/keywords/cancer-stem-cells","display_name":"cancer stem cells","score":0.8230000138282776},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9509999752044678},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9879999756813049},{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.9950000047683716},{"id":"https://openalex.org/keywords/chimeric-promoter","display_name":"chimeric promoter","score":0.6769999861717224},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.7620000243186951},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5239999890327454},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.5210000276565552},{"id":"https://openalex.org/keywords/viral-oncolysis","display_name":"viral oncolysis","score":0.4180000126361847},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.460999995470047},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.40400001406669617}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.9025771021842957},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.7991718649864197},{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.7977876663208008},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.706567645072937},{"id":"https://openalex.org/C2777283488","wikidata":"https://www.wikidata.org/wiki/Q7095181","display_name":"Oncolytic adenovirus","level":4,"score":0.6536102890968323},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.6285238265991211},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6042908430099487},{"id":"https://openalex.org/C56219504","wikidata":"https://www.wikidata.org/wiki/Q7900869","display_name":"Urokinase receptor","level":3,"score":0.54915452003479},{"id":"https://openalex.org/C2910430875","wikidata":"https://www.wikidata.org/wiki/Q7251413","display_name":"Nab-paclitaxel","level":4,"score":0.48514947295188904},{"id":"https://openalex.org/C161879069","wikidata":"https://www.wikidata.org/wiki/Q904082","display_name":"Notch signaling pathway","level":3,"score":0.46297332644462585},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.368383526802063},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.31899750232696533},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30136746168136597},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.26731401681900024},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.13125163316726685},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.10581400990486145}],"mesh":[{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000256","descriptor_name":"Adenoviridae","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000418","descriptor_name":"Albumins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014411","descriptor_name":"Neoplastic Stem Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D014411","descriptor_name":"Neoplastic Stem Cells","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014411","descriptor_name":"Neoplastic Stem Cells","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D050130","descriptor_name":"Oncolytic Virotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051880","descriptor_name":"Receptors, Notch","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D055293","descriptor_name":"Receptors, Urokinase Plasminogen Activator","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.18632/oncotarget.15169","doi":"https://doi.org/10.18632/oncotarget.15169","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.15169","pdf_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=15169&path%5B%5D=48514","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},{"id":"pmid:28186974","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28186974","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5410256","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5410256/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.18632/oncotarget.15169","doi":"https://doi.org/10.18632/oncotarget.15169","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.15169","pdf_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=15169&path%5B%5D=48514","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9789000153541565,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2678996418","display_name":null,"funder_award_id":"BIO2015-68990-REDT","funder_id":"https://openalex.org/F4320335322","funder_display_name":"European Regional Development Fund"},{"id":"https://openalex.org/G5356627205","display_name":null,"funder_award_id":"IIS10/00014","funder_id":"https://openalex.org/F4320321505","funder_display_name":"Generalitat de Catalunya"},{"id":"https://openalex.org/G6323242213","display_name":null,"funder_award_id":"IIS10/00014","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G6964282679","display_name":null,"funder_award_id":"BIO2015-68990-REDT","funder_id":"https://openalex.org/F4320321505","funder_display_name":"Generalitat de Catalunya"}],"funders":[{"id":"https://openalex.org/F4320315803","display_name":"Centres de Recerca de Catalunya","ror":"https://ror.org/01bkbaq61"},{"id":"https://openalex.org/F4320321505","display_name":"Generalitat de Catalunya","ror":"https://ror.org/01bg62x04"},{"id":"https://openalex.org/F4320334923","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886"},{"id":"https://openalex.org/F4320335322","display_name":"European Regional Development Fund","ror":"https://ror.org/00k4n6c32"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2587007231.pdf","grobid_xml":"https://content.openalex.org/works/W2587007231.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W1508810837","https://openalex.org/W1535328112","https://openalex.org/W1828873947","https://openalex.org/W1978003260","https://openalex.org/W1987708512","https://openalex.org/W1992668179","https://openalex.org/W1998149120","https://openalex.org/W2002355858","https://openalex.org/W2002731985","https://openalex.org/W2008818697","https://openalex.org/W2013732926","https://openalex.org/W2029770190","https://openalex.org/W2052828768","https://openalex.org/W2056459029","https://openalex.org/W2056782307","https://openalex.org/W2057881265","https://openalex.org/W2058346192","https://openalex.org/W2073898602","https://openalex.org/W2074899031","https://openalex.org/W2075639945","https://openalex.org/W2077945404","https://openalex.org/W2083425643","https://openalex.org/W2087007992","https://openalex.org/W2091522264","https://openalex.org/W2095483969","https://openalex.org/W2104970490","https://openalex.org/W2110292794","https://openalex.org/W2132387165","https://openalex.org/W2139251549","https://openalex.org/W2144624167","https://openalex.org/W2147871659","https://openalex.org/W2148054025","https://openalex.org/W2162306027","https://openalex.org/W2162828533","https://openalex.org/W2164942973","https://openalex.org/W2166208703","https://openalex.org/W2262278676","https://openalex.org/W2346435170","https://openalex.org/W4324263428"],"related_works":["https://openalex.org/W2056782307","https://openalex.org/W2162306027","https://openalex.org/W2053328421","https://openalex.org/W2910296604","https://openalex.org/W2561702080","https://openalex.org/W2008818697","https://openalex.org/W2058346192","https://openalex.org/W2009796329","https://openalex.org/W4407058608","https://openalex.org/W2202891681"],"abstract_inverted_index":{"//":[0],"Ana":[1],"Mato-Berciano":[2],"1,":[3,8,14,28],"2":[4,9,15,29,41],",":[5,10,16,20,25],"Giulia":[6],"Raimondi":[7],"Maria":[11],"Victoria":[12],"Maliandi":[13],"Ramon":[17],"Alemany":[18],"3":[19,54],"Lluis":[21],"Montoliu":[22],"2,":[23],"4":[24,63],"Cristina":[26,73],"Fillat":[27],"1":[30],"Institut":[31,55],"d\u2019Investigacions":[32],"Biom\u00e8diques":[33],"August":[34],"Pi":[35],"i":[36],"Sunyer":[37],"(IDIBAPS),":[38],"Barcelona,":[39,52,61],"Spain":[40,53,62,70],"Centro":[42,64],"de":[43,48,59,66],"Investigaci\u00f3n":[44],"Biom\u00e9dica":[45],"en":[46],"Red":[47],"Enfermedades":[49],"Raras":[50],"(CIBERER),":[51],"Catal\u00e0":[56],"d\u2019Oncologia-IDIBELL.":[57],"L\u2019Hospitalet":[58],"Llobregat,":[60],"Nacional":[65],"Biotecnologia":[67],"(CNB-CSIC),":[68],"Madrid,":[69],"Correspondence":[71],"to:":[72],"Fillat,":[74],"email:":[75],"cfillat@clinic.ub.es":[76],"Keywords:":[77],"pancreatic":[78,111,205,266],"cancer,":[79],"oncolytic":[80,126,190,331],"adenovirus,":[81,332],"cancer":[82,112,116,206,267],"stem":[83,117,207],"cells,":[84],"gemcitabine,":[85],"nab-paclitaxel":[86],"Received:":[87],"February":[88,96],"08,":[89],"2016":[90],"Accepted:":[91],"January":[92],"23,":[93],"2017":[94,98],"Published:":[95],"07,":[97],"ABSTRACT":[99],"Notch":[100,132,196,254],"signaling":[101],"pathway":[102],"is":[103],"an":[104],"embryonic":[105],"program":[106],"that":[107,247,334],"becomes":[108],"reactivated":[109],"in":[110,129,135,153,184,188,201,217,230,256,265,276,283,304],"and":[113,155,187,198,204,214,219,258,270,285,337,343],"contributes":[114],"to":[115,131,149,195,238,253,289,296],"cell":[118,202,268,319],"(CSC)":[119],"maintenance.":[120],"We":[121,157,245],"explored":[122,158],"the":[123,136,159,173,189,240,311],"concept":[124],"of":[125,138,161,242,293,310,317],"adenoviral":[127,185],"activity":[128,152,275],"response":[130,194,303],"activation":[133,255],"signaling,":[134,197],"context":[137],"a":[139,147,162,178,290,328],"chimeric":[140],"promoter":[141,181],"with":[142,232,341],"uPAR":[143,180],"regulatory":[144],"sequences,":[145],"as":[146,227],"strategy":[148],"drive":[150],"its":[151],"neoplastic":[154],"CSC.":[156],"advantages":[160],"chemo-virotherapy":[163],"approach":[164],"based":[165],"on":[166],"synergistic":[167,339],"combinations.":[168],"Regulatory":[169],"sequences":[170,251],"recognized":[171],"by":[172,322],"transcriptional":[174],"factor":[175],"CSL":[176],"upstream":[177],"minimal":[179],"were":[182,236],"engineered":[183],"vectors":[186],"adenovirus":[191],"AdNuPARmE1A.":[192,259],"Viral":[193],"viral":[199,315],"potency":[200],"lines":[203,269],"cells":[208],"(PCSC)":[209],"was":[210,225],"tested.":[211],"Preclinical":[212],"toxicity":[213],"antitumor":[215,281],"efficacy":[216],"xenografts":[218,221],"Patient-derived":[220],"(PDX)":[222],"mouse":[223],"models":[224],"evaluated,":[226],"unimodal":[228],"or":[229],"combination":[231,312],"gemcitabine+nab-paclitaxel.":[233],"Mechanistic":[234],"studies":[235],"conducted":[237],"explore":[239],"synergism":[241],"combined":[243],"therapies.":[244],"demonstrate":[246],"CSL-binding":[248],"site":[249],"optimized-engineered":[250],"respond":[252],"AdNuPARmLuc":[257],"AdNuPARmE1A":[260,272,333],"showed":[261],"strong":[262],"lytic":[263],"effects":[264,282,309,340],"PCSC.":[271],"displayed":[273],"attenuated":[274],"normal":[277],"tissues,":[278],"but":[279],"robust":[280],"xenograft":[284],"PDX":[286],"models,":[287],"leading":[288],"reduced":[291],"capacity":[292],"treated":[294],"tumors":[295],"form":[297],"tumorspheres.":[298],"Chemo-virotherapy":[299],"treatment":[300],"enlarged":[301],"therapeutic":[302],"both":[305],"tumor":[306],"models.":[307],"Synergistic":[308],"resulted":[313],"from":[314],"sensitization":[316],"apoptotic":[318],"death":[320],"triggered":[321],"chemotherapy.":[323],"In":[324],"summary":[325],"we":[326],"present":[327],"novel":[329],"effective":[330],"reduces":[335],"PCSC":[336],"presents":[338],"gemcitabine":[342],"nab-paclitaxel,":[344],"supporting":[345],"further":[346],"clinical":[347],"development.":[348]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2017-02-17T00:00:00"}